Ndausung Udongwo

Ndausung Udongwo

Auto-generated profile, based on publicly available information

Ndausung Udongwo

Department of Medicine, Jersey Shore University Medical Center, Neptune, NJ 07753, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
TATemidayo Abe
Temidayo Abe
TOTitilope Olanipekun
Titilope Olanipekun
DADemilade Adedinsewo
Demilade Adedinsewo
OOOluseye Ogunmoroti
Oluseye Ogunmoroti
NUNdausung Udongwo
Ndausung Udongwo
EMErin D. Michos
Erin D. Michos
Background: Although there has been a decrease in the incidence of ST‐segment–elevation myocardial infarction (STEMI) in the United States, this trend might be stagnant or increasing in young women. We assessed the trends, characteristics, and outcomes of STEMI in women aged 18 to 55 years. Methods and Results: We identified 177 602 women aged 18 to 55 with the primary diagnosis of STEMI from the National Inpatient Sample during years 2008 to 2019. We performed trend analyses to assess hospitalization rates, cardiovascular disease (CVD) risk factor profile, and in‐hospital outcomes stratified by three age subgroups (18–34, 35–44, and 45–55 years). We found STEMI hospitalization rates were decreased in the overall study cohort from 52 per 100 000 hospitalizations in 2008 to 36 per 100 000 in 2019. This was driven by decreased proportion of hospitalizations in women aged 45 to 55 years (74.2% to–71.7%; P <0.001). Proportion of STEMI hospitalizationincreased in women aged 18–34 (4.7%–5.5%; P <0.001) and 35–44 years (21.2%–22.7%; P <0.001). The prevalence of traditional and non‐traditional female‐specific or female‐predominant CVD risk factors increased in all age subgroups. The adjusted odds of in‐hospital mortality in the overall study cohort and age subgroups were unchanged throughout the study period. Additionally, we observed an increase in the adjusted odds of cardiogenic shock, acute stroke, and acute kidney injury in the overall cohort over the study period. Conclusions: STEMI hospitalizations are increasing among women aged <45 years, and in‐hospital mortality has not changed over the past 12 years in women aged <55 years. Future studies on the optimization of risk assessment and management of STEMI in young women are urgently needed.

1 May 2022 in Journal of Clinical Medicine Research
Verified
Journal Article
Open access
PDF file
LNLakshmi Rekha Narra
Lakshmi Rekha Narra
NUNdausung Udongwo
Ndausung Udongwo
JDJerry Lorren Dominic
Jerry Lorren Dominic
SDShriya Doreswamy
Shriya Doreswamy
ABAnam Bhasir
Anam Bhasir
COChinwe Ogedegbe
Chinwe Ogedegbe
Obesity and the Other Independent Predictors in Elective Endotracheal Tube Intubations: A Narrative Review

1 December 2021 in Journal of Medical Cases
Verified
Journal Article
Open access
PDF file
AAAsseel Al-Bayati
Asseel Al-Bayati
KWKyle Wiseman
Kyle Wiseman
NUNdausung Udongwo
Ndausung Udongwo
FAFiras Ajam
Firas Ajam
RHRiple Hansalia
Riple Hansalia
RARenato Apolito
Renato Apolito
Ticagrelor is a direct and rapid-acting antagonist of the P2Y12-adenosine diphosphate receptor found on platelets. The drug is recommended as a first-line antiplatelet agent in patients with acute coronary syndromes, as evidenced in its superiority compared to clopidogrel according to the Platelet Inhibition and Patient Outcomes study. Specifically, the mechanism of action has been proven to show higher inhibition and less variability in its action on P2Y12 receptors compared to clopidogrel. Additionally, ticagrelor inhibits the equilibrative nucleoside transporter 1 adenosine transporter protein leading to an increased concentration of adenosine in the blood, particularly at sites of ischemia. This effect increases the biological efficacy of ticagrelor in terms of cardioprotection, anticoagulation effects, and anti-inflammatory effects. However, the effects are also thought to be responsible for some of the adverse pharmacological effects reported with ticagrelor, such as bradycardia and ventricular pauses > 3 seconds. Herein, we report a case of recurrent sinus arrest and ventricular asystole in a patient pre-treated with ticagrelor and subsequent physiological assessment of a coronary lesion with fractional flow reserve using intravenous adenosine infusion. J Med Cases. 2021;12(12):499-502 doi: https://doi.org/10.14740/jmc3815

25 September 2022 in Cureus
Verified
Journal Article
Open access
SISteven Imburgio
Steven Imburgio
KWKyle Wiseman
Kyle Wiseman
NUNdausung Udongwo
Ndausung Udongwo
DGDhairya Gor
Dhairya Gor
DDDhaval Desai
Dhaval Desai
RARenato Apolito
Renato Apolito
Atrial septal aneurysm (ASA) is a condition involving the bulging of the interatrial septum into one or both of the atrial chambers. We present the case of an ASA found on transesophageal echocardiogram in a patient who presented with exertional dyspnea. This case report aims to highlight the growing clinical association of ASA with arterial embolism through various mechanisms and emphasize the unknown aspects of clinical management for such patients. While there are currently no clear recommendations on whether to start anticoagulation after an ASA is diagnosed, many suggest a careful patient-centered approach for such decisions due to the reported increased risk of thromboembolic events. Further studies regarding the significance of ASA and cardioembolic events are needed.

24 August 2022 in Cureus
Verified
Journal Article
Open access
EOErik Olson
Erik Olson
MMMinhaz Murshad
Minhaz Murshad
TATasnuva Amin
Tasnuva Amin
NUNdausung Udongwo
Ndausung Udongwo
SCSaira Chaughtai
Saira Chaughtai
MHMohammmad Hossain
Mohammmad Hossain
Legionella is most known for causing pneumonia. However, it is a systemic disease that can directly cause severe multi-organ injury in what is sometimes referred to as "extrapulmonary Legionella." In this case report, a reasonably healthy 80-year-old man is found to have Legionella pneumonia complicated by rhabdomyolysis with acute, severe, non-oliguric acute kidney injury, uremic encephalopathy, transaminitis, and cerebellar dysfunction. With a 14-day course of azithromycin and prompt initiation of dialysis, the patient’s pneumonia and systemic sequelae improved. This case demonstrates the importance of considering Legionella in the differential diagnosis of patients who present with community-acquired pneumonia and multi-organ dysfunction. Prompt diagnosis and management may decrease mortality associated with this disease sequela.

23 October 2022 in Cureus
Verified
Journal Article
Open access
OOOmotola Oredipe
Omotola Oredipe
AJAnmol S. Johal
Anmol S. Johal
COChinwendu Onuegbu
Chinwendu Onuegbu
AKAyoola Kalejaiye
Ayoola Kalejaiye
COChiugo Okoye
Chiugo Okoye
SPSwapnil Patel
Swapnil Patel
Hydrocephalus is the accumulation of cerebrospinal fluid (CSF) in the cerebral ventricles and is considered an emergency in acute presentation. Hydrocephalus typically presents with symptoms of headache, nausea, vomiting, lethargy, vision changes and seizure; furthermore, narrowing down the underlying etiology of hydrocephalus can aid in treatment and management options. We present a rare case of a patient that presented with a recent diagnosis of COVID-19 and was found to have acute hydrocephalus and stroke. The aim of this case report is to explore the link between COVID-19 and the development of hydrocephalus and stroke by delineating the underlying pathophysiology of COVID-19 as well as the etiologies of hydrocephalus and possible management strategies. We hope to highlight the importance of keeping an open differential for presentations of headaches and also emphasize the potential complications of COVID-19 infection to help better patient outcomes.